Background Background Depression following
Depression following myocardial infarction is associated with myocardial infarction is associated with poor cardiac prognosis.It is unclear poor cardiac prognosis.It is unclear whether antidepressanttreatment whether antidepressanttreatment improves long-term depression status and improves long-term depression status and cardiac prognosis. cardiac prognosis.
Aims Aims To evaluate the effects of
To evaluate the effects of antidepressanttreatment compared with antidepressanttreatment compared with usual care in an effectiveness study. usual care in an effectiveness study.
Method Method In a multicentre randomised
In a multicentre randomised controlled trial, 2177 myocardialinfarction controlled trial, 2177 myocardialinfarction patients were evaluated for ICD^10 patients were evaluated for ICD^10 depression and randomised to depression and randomised to intervention ( intervention (n n¼209) or care as usual 209) or care as usual ( (n n¼122).Both arms were evaluated at18 122).Both arms were evaluated at18 months post-myocardial infarction for months post-myocardial infarction for long-term depression status and new long-term depression status and new cardiac events. cardiac events.
Results

Results No differences were observed
No differences were observed between intervention and control groups between intervention and control groups in mean scores on the Beck Depression in mean scores on the Beck Depression Inventory (11.0, s.d. Inventory (11.0, s.d.¼7.5 7.5 v. v.10.2, s.d. 10.2, s.d.¼5 .1, 5.1, P P¼0.45) or presence of ICD^10 0.45) or presence of ICD^10 depression (30.5 depression (30.5 v. v. 32.1%, 32.1%, P P¼0.68). 0.68).The The cardiac event rate was14% among the cardiac event rate was14% among the intervention group and13% among intervention group and13% among controls (OR controls (OR¼1.07,95% CI 0.57^2.00).
1.07,95% CI 0.57^2.00).
Conclusions
Conclusions Antidepressant Antidepressant treatment did not alter long-term treatment did not alter long-term depression post-myocardial infarction depression post-myocardial infarction status or improve cardiac prognosis. status or improve cardiac prognosis.
Declaration of interest
Declaration of interest None.
None. Funding detailed in Acknowledgements. Funding detailed in Acknowledgements.
Depression is one of the most potent Depression is one of the most potent psychosocial risk factors for a poor psychosocial risk factors for a poor cardiovascular prognosis after myocardial cardiovascular prognosis after myocardial infarction (Hemingway & Marmot, infarction (Hemingway & Marmot, 1999) . A recent meta-analysis (Van Melle 1999) . A recent meta-analysis (Van Melle et al et al, 2004) showed that depression post-, 2004) showed that depression postmyocardial infarction was associated with myocardial infarction was associated with a 2-to 2.5-fold increased risk for all-cause a 2-to 2.5-fold increased risk for all-cause mortality, cardiovascular mortality and mortality, cardiovascular mortality and cardiovascular events. In addition, deprescardiovascular events. In addition, depression post-myocardial infarction is a major sion post-myocardial infarction is a major cause of incomplete recovery (Ladwig cause of incomplete recovery (Ladwig et et al al, 1994) , poor quality of life (Beck , 1994) , poor quality of life (Beck et al et al, , 2001 ), delayed return to work (Soderman 2001) , delayed return to work (Soderman et al et al, 2003) , non-adherence (Carney , 2003) , non-adherence (Carney et al et al, , 1995) , and non-attendance at cardiac reha-1995), and non-attendance at cardiac rehabilitation (Lane bilitation (Lane et al et al, 2001) . It is estimated , 2001). It is estimated that approximately 1 out of 5 patients has that approximately 1 out of 5 patients has depression post-myocardial infarction depression post-myocardial infarction (Schleifer (Schleifer et al et al, 1989) . , 1989). Two intervention studies have assessed Two intervention studies have assessed the effects of treatment of depression postthe effects of treatment of depression postmyocardial infarction. In the ENhancing myocardial infarction. In the ENhancing Recovery in Coronary Heart Disease study Recovery in Coronary Heart Disease study (ENRICHD), the effects of cognitive-(ENRICHD), the effects of cognitivebehavioural therapy (CBT) on depression behavioural therapy (CBT) on depression and cardiac prognosis was evaluated and cardiac prognosis was evaluated (Berkman (Berkman et al et al, 2003) . In this large trial, , 2003) . In this large trial, no significant difference in cardiac outno significant difference in cardiac outcomes was found between the intervention comes was found between the intervention and the care as usual arms. Although and the care as usual arms. Although substantial improvement in depression substantial improvement in depression status was observed 6 months after initiastatus was observed 6 months after initiation of CBT, the difference between the tion of CBT, the difference between the arms diminished over time and was no arms diminished over time and was no longer present after 30 months. longer present after 30 months.
The SADHART study (Glassman The SADHART study (Glassman et al et al, , 2002) found sertraline to be a safe treat-2002) found sertraline to be a safe treatment for depression post-myocardial inment for depression post-myocardial infarction, but there was little difference in farction, but there was little difference in depression status between groups receiving depression status between groups receiving sertraline and placebo after 24 weeks of sertraline and placebo after 24 weeks of treatment. However, the effect of sertraline treatment. However, the effect of sertraline was greater in the patients with severe and was greater in the patients with severe and recurrent depression. The study was not recurrent depression. The study was not designed to assess the effects of treatment designed to assess the effects of treatment on cardiovascular prognosis, but severe on cardiovascular prognosis, but severe cardiovascular events during the 6-month cardiovascular events during the 6-month treatment tended to be less frequent in the treatment tended to be less frequent in the sertraline group. The effects of sertraline sertraline group. The effects of sertraline on long-term depression status were not on long-term depression status were not evaluated. evaluated.
Thus, little is known about the effects of Thus, little is known about the effects of treatment for depression post-myocardial treatment for depression post-myocardial infarction on either long-term depression infarction on either long-term depression status or cardiac prognosis. We have status or cardiac prognosis. We have conducted the Myocardial INfarction and conducted the Myocardial INfarction and Depression -Intervention Trial (MIND-IT) Depression -Intervention Trial (MIND-IT) in order to determine, using a randomised in order to determine, using a randomised controlled design, whether antidepressant controlled design, whether antidepressant treatment for depression post-myocardial treatment for depression post-myocardial infarction improves long-term depression infarction improves long-term depression status and cardiovascular prognosis (Van status and cardiovascular prognosis (Van den Brink den Brink et al et al, 2002) . The MIND-IT is , 2002). The MIND-IT is an effectiveness study rather than an effian effectiveness study rather than an efficacy study, and compares the effects of an cacy study, and compares the effects of an active treatment strategy with usual care. active treatment strategy with usual care.
METHOD METHOD
Study participants Study participants
The inclusion and exclusion criteria for The inclusion and exclusion criteria for this trial have been described previously this trial have been described previously ( Van (Gillum et al et al, 1984) , 1984) for definite myocardial infarction: infor definite myocardial infarction: increased cardiac enzymes and either electrocreased cardiac enzymes and either electrocardiographic changes or chest pain. cardiographic changes or chest pain. Patients were excluded if the index Patients were excluded if the index myocardial infarction occurred during a myocardial infarction occurred during a hospitalisation for another medical conhospitalisation for another medical condition (except for unstable angina pectoris), dition (except for unstable angina pectoris), if they were unable to participate in study if they were unable to participate in study procedures (e.g. unable to communicate or procedures (e.g. unable to communicate or not available for follow-up), had any other not available for follow-up), had any other disease likely to influence short-term disease likely to influence short-term survival, were already receiving psychiatric survival, were already receiving psychiatric treatment for depression, or were treatment for depression, or were participating in another clinical trial. participating in another clinical trial.
The institutional review board at each The institutional review board at each clinical centre approved the study protocol clinical centre approved the study protocol and all patients provided written informed and all patients provided written informed consent before enrolment. In the study consent before enrolment. In the study information pack it was emphasised that, information pack it was emphasised that, although all participating patients were to although all participating patients were to be screened for depression, antidepressant be screened for depression, antidepressant treatment would be offered only to a treatment would be offered only to a random sample of patients and all were free random sample of patients and all were free to seek help for mood problems. to seek help for mood problems.
Design of the study Design of the study
Patients admitted with an acute myocardial Patients admitted with an acute myocardial infarction were screened for depressive infarction were screened for depressive symptoms during hospitalisation and at 3, symptoms during hospitalisation and at 3, 6, 9 and 12 months post-myocardial infarc-6, 9 and 12 months post-myocardial infarction, using the Beck Depression Inventory tion, using the Beck Depression Inventory (BDI; Beck, 1979) . Those with depressive (BDI; Beck, 1979 ICD-10 Organization, 1993) according to ICD-10 (further: 'depression') were randomised (further: 'depression') were randomised (1:1) to antidepressant treatment or care (1:1) to antidepressant treatment or care as usual. The assignment as usual. The assignment was carried out was carried out at the Trial Coordination Centre in Groninat the Trial Coordination Centre in Groningen with the use of computer-generated gen with the use of computer-generated perpermuted blocks of four, stratified according muted blocks of four, stratified according to clinical site and time of onset of depresto clinical site and time of onset of depression (within 6 months sion (within 6 months v.
v. 6 months or more 6 months or more post-myocardial infarction). Because the post-myocardial infarction). Because the number of patients actually treated with number of patients actually treated with antidepressants was lower than expected, antidepressants was lower than expected, the randomisation ratio was changed to the randomisation ratio was changed to 2:1 on 14 March 2001. Patients with a sig-2:1 on 14 March 2001. Patients with a significant risk of suicide were excluded from nificant risk of suicide were excluded from randomisation and referred for treatment randomisation and referred for treatment outside the study. To compare both strateoutside the study. To compare both strategies, we used the Zelen design (Zelen, gies, we used the Zelen design (Zelen, 1979) : patients allocated to the 'care as 1979): patients allocated to the 'care as usual' arm were not informed about their usual' arm were not informed about their research diagnosis of depression to avoid research diagnosis of depression to avoid influencing usual care. Data management influencing usual care. Data management was independently performed at the Trial was independently performed at the Trial Coordination Centre, Groningen, The Coordination Centre, Groningen, The Netherlands. Netherlands.
Baseline variables Baseline variables
Data were collected on demographics, medData were collected on demographics, medical history, clinical variables and mediical history, clinical variables and medication use during hospitalisation for the cation use during hospitalisation for the index myocardial infarction. The cumulaindex myocardial infarction. The cumulative burden of medical comorbidity was tive burden of medical comorbidity was assessed with a modified version of the assessed with a modified version of the Charlson Comorbidity Index (Watkins Charlson Comorbidity Index (Watkins et et al al, 2003) . Higher scores on this scale indi-, 2003) . Higher scores on this scale indicate more comorbidity. To account for a cate more comorbidity. To account for a possible relationship between depression possible relationship between depression post-myocardial infarction and cardiac post-myocardial infarction and cardiac disease severity, the following parameters disease severity, the following parameters of risk stratification were assessed: Killip of risk stratification were assessed: Killip class at admission, maximum values of class at admission, maximum values of serum aspartate transaminase during hospiserum aspartate transaminase during hospitalisation, left ventricular ejection fraction talisation, left ventricular ejection fraction (as measured by either echocardiography (as measured by either echocardiography or radionuclide ventriculography) and wall or radionuclide ventriculography) and wall motion score index (WMSI) according to motion score index (WMSI) according to the recommendations of the American the recommendations of the American Society of Echocardiography (Schiller Society of Echocardiography (Schiller et al et al, , 1989) . Independent analysis was 1989). Independent analysis was performed performed at the core echocardiography laboratory by at the core echocardiography laboratory by technicians who were unaware of the technicians who were unaware of the patients' randomisation status. patients' randomisation status.
Antidepressant intervention Antidepressant intervention
The MIND-IT study was designed as an The MIND-IT study was designed as an effectiveness study comparing active antieffectiveness study comparing active antidepressant treatment with usual care. In depressant treatment with usual care. In the intervention arm, the research diagnosis the intervention arm, the research diagnosis provided by the CIDI interview was conprovided by the CIDI interview was confirmed by a psychiatrist prior to the patient firmed by a psychiatrist prior to the patient starting antidepressant treatment. Several starting antidepressant treatment. Several treatment modalities were possible. Flextreatment modalities were possible. Flexibility in treatment was permitted because ibility in treatment was permitted because the main research question was whether the main research question was whether implementing any active depression treatimplementing any active depression treatment strategy would be associated with ment strategy would be associated with better outcomes than usual care in which better outcomes than usual care in which antidepressant treatment is almost negligiantidepressant treatment is almost negligible (Frasure-Smith ble (Frasure-Smith et al et al, 1993) . , 1993). However, However, allocation to these modalities was strictly allocation to these modalities was strictly defined in the protocol. First-choice treatdefined in the protocol. First-choice treatment was double-blind placebo-controlled ment was double-blind placebo-controlled treatment with the selective noradrenaline treatment with the selective noradrenaline reuptake inhibitor mirtazapine (a nonreuptake inhibitor mirtazapine (a nontricyclic, presynaptic tricyclic, presynaptic a a 2 2 -antagonist which -antagonist which enhances both noradrenergic and serotoenhances both noradrenergic and serotonergic neurotransmission; De Boer, 1996) . nergic neurotransmission; De Boer, 1996) . In case of refusal or insufficient treatment In case of refusal or insufficient treatment response after 8 weeks, open treatment response after 8 weeks, open treatment with the selective serotonin reuptake inwith the selective serotonin reuptake inhibitor (SSRI) citalopram was offered hibitor (SSRI) citalopram was offered (Montgomery & Djarv, 1996) . Sufficient (Montgomery & Djarv, 1996) . Sufficient treatment response was defined as at least treatment response was defined as at least 50% reduction on the Hamilton Depres-50% reduction on the Hamilton Depression sion Rating Scale (HDRS; Hamilton, Rating Scale (HDRS; Hamilton, 1960) compared with baseline score or a 1960) compared with baseline score or a HDRS score at 8 weeks of HDRS score at 8 weeks of 4 49. Thus, 9. Thus, patients who were initially treated with patients who were initially treated with placebo and who did not improve within placebo and who did not improve within 8 weeks were subsequently treated with 8 weeks were subsequently treated with an SSRI. The third option was 'tailored an SSRI. The third option was 'tailored treatment' which was at the discretion of treatment' which was at the discretion of the clinical psychiatrist (e.g. SSRI, the clinical psychiatrist (e.g. SSRI, psychotherapy, etc.). Patients were schedpsychotherapy, etc.). Patients were scheduled to visit the psychiatrist on average uled to visit the psychiatrist on average once a month during the treatment period once a month during the treatment period of 6 months. In the care as usual arm, of 6 months. In the care as usual arm, psychiatric treatment outside the study psychiatric treatment outside the study was recorded but no treatment was offered was recorded but no treatment was offered by the MIND-IT investigators. Whether by the MIND-IT investigators. Whether the patient was referred for cardiac rehabilithe patient was referred for cardiac rehabilitation was left to the discretion of the tation was left to the discretion of the patient's cardiologist (who was masked to patient's cardiologist (who was masked to the psychiatric screening results). the psychiatric screening results).
Long-term depression status and Long-term depression status and quality of life quality of life At approximately 18 months postAt approximately 18 months postmyocardial infarction, the course and outmyocardial infarction, the course and outcome of the depressive episode was assessed come of the depressive episode was assessed in a CIDI interview. The BDI was adminisin a CIDI interview. The BDI was administered to evaluate the severity of depressive tered to evaluate the severity of depressive symptoms. In addition, health-related qualsymptoms. In addition, health-related quality of life was assessed with the RAND 36-ity of life was assessed with the RAND 36-item Health Survey, which consists of 36 item Health Survey, which consists of 36 items organised into eight scales (Ware items organised into eight scales (Ware et et al al, 1993; Essink-Bot , 1993; Essink-Bot et al et al, 1997) . Somatic , 1997) . Somatic health complaints were assessed with health complaints were assessed with the Health Complaints Scale (HCS), a the Health Complaints Scale (HCS), a self-report measure to assess common self-report measure to assess common health complaints in patients with coronary health complaints in patients with coronary heart disease (Denollet, 1994) . Disability heart disease (Denollet, 1994) . Disability was assessed according to Broadhead was assessed according to Broadhead et al et al (1990) . Patients were asked to indicate with (1990). Patients were asked to indicate with a time frame of the past month: 'how many a time frame of the past month: 'how many days were you not able to do your daily acdays were you not able to do your daily activities (for example your work, housetivities (for example your work, housework, studies, leisure activities) owing to work, studies, leisure activities) owing to physical or emotional problems?' and physical or emotional problems?' and 'apart from the above, on how many days 'apart from the above, on how many days were you able to do your daily activities were you able to do your daily activities for less than half of the time owing to for less than half of the time owing to physical or emotional problems?' Both physical or emotional problems?' Both complete and partial disability were catecomplete and partial disability were categorised as having been present for either gorised as having been present for either less than 1 week or for 1 week or more less than 1 week or for 1 week or more during the previous month. during the previous month.
Cardiac events Cardiac events
The occurrence of any significant cardiac The occurrence of any significant cardiac event served as the primary end-point for event served as the primary end-point for the study. Cardiac events included cardiac the study. Cardiac events included cardiac death or hospital admission for docudeath or hospital admission for documented non-fatal myocardial infarction, mented non-fatal myocardial infarction, myocardial ischaemia, coronary revascularmyocardial ischaemia, coronary revascularisation (coronary angioplasty or bypass isation (coronary angioplasty or bypass surgery), heart failure or ventricular tachysurgery), heart failure or ventricular tachycardia occurring in the time between cardia occurring in the time between randomisation and 18 months postrandomisation and 18 months postmyocardial infarction. Time to follow-up myocardial infarction. Time to follow-up (6-15 months) depended on the time of (6-15 months) depended on the time of randomisation (range 3 months to 12 randomisation (range 3 months to 12 months post-myocardial infarction). Other months post-myocardial infarction). Other cardiac-related hospital admissions (defined cardiac-related hospital admissions (defined as admissions with an initial evaluation by as admissions with an initial evaluation by a cardiologist or hospitalisations at the a cardiologist or hospitalisations at the cardiology ward) were considered as cardiology ward) were considered as secondary end-points. Potential end-points secondary end-points. Potential end-points were recorded at 12 months and 18 months were recorded at 12 months and 18 months post-myocardial infarction, and were repost-myocardial infarction, and were reviewed and classified according to previewed and classified according to prespecified, established criteria (Cannon specified, established criteria (Cannon et et al al, 2001 ) by an independent end-point , 2001 ) by an independent end-point committee that was unaware of patients' committee that was unaware of patients' treatment assignments. Discrepancies were treatment assignments. Discrepancies were discussed until agreement was reached. discussed until agreement was reached.
Statistical analysis Statistical analysis
Study power was calculated for long-term Study power was calculated for long-term depression outcomes and cardiac events. depression outcomes and cardiac events. With respect to the long-term depression With respect to the long-term depression status, a sample of 320 randomised patients status, a sample of 320 randomised patients would result in a study power of 80%, would result in a study power of 80%, assuming a drop-out rate of 20% and a assuming a drop-out rate of 20% and a small-to-medium effect size (0.35). With resmall-to-medium effect size (0.35). With respect to cardiac events, we expected a 12-spect to cardiac events, we expected a 12-month incidence of 38% for patients with month incidence of 38% for patients with depression and 19% for patients without depression and 19% for patients without depression (Frasure-Smith depression (Frasure-Smith et al et al, 1995) . If , 1995) . If psychiatric treatment could reduce the risk psychiatric treatment could reduce the risk for patients with depression from 38 to 25% for patients with depression from 38 to 25% (i.e. reduction of the attributable risk by (i.e. reduction of the attributable risk by two-thirds), 190 patients in the intervention two-thirds), 190 patients in the intervention arm and 130 in the care as usual arm would arm and 130 in the care as usual arm would give a statistical power of 0.84 to detect this give a statistical power of 0.84 to detect this effect with a log-rank test ( effect with a log-rank test (a a¼0.05). 0.05). t t-tests were used to compare normally -tests were used to compare normally distributed continuous variables and the distributed continuous variables and the w w 2 2 -test was used to compare categorical -test was used to compare categorical data. Time-to-event data were analysed data. Time-to-event data were analysed with the Kaplan-Meier method and differwith the Kaplan-Meier method and differences between care as usual and intervenences between care as usual and intervention groups in the incidence of cardiac tion groups in the incidence of cardiac events were assessed with the log-rank test. events were assessed with the log-rank test. Outcome data were considered at 18 Outcome data were considered at 18 months post-myocardial infarction, the months post-myocardial infarction, the time time of last contact, withdrawal from the of last contact, withdrawal from the study, or at the time of a primary endstudy, or at the time of a primary endpoint. All point. All P P values were two-tailed. values were two-tailed.
RESULTS RESULTS
A total of 4780 myocardial infarction A total of 4780 myocardial infarction patients were assessed for eligibility patients were assessed for eligibility (Fig. 1 ). Of these, 1403 (29%) met one or (Fig. 1 ). Of these, 1403 (29%) met one or 4 6 2 4 6 2 AUTHOR'S PROOF AUTHOR'S PROOF more exclusion criteria, and of the excluded more exclusion criteria, and of the excluded patients, 104 were receiving treatment for patients, 104 were receiving treatment for depression (see Table 1 for reasons for exdepression (see Table 1 for reasons for exclusion). Of the 3377 remaining patients, clusion). Of the 3377 remaining patients, 1200 refused to participate and 2177 were 1200 refused to participate and 2177 were included (64%). During the screening periincluded (64%). During the screening period from 3 to 12 months post-myocardial od from 3 to 12 months post-myocardial infarction, 375 patients (17.2%) met the infarction, 375 patients (17.2%) met the ICD-10 criteria for depression. After exclu-ICD-10 criteria for depression. After exclusion of potentially suicidal patients ( sion of potentially suicidal patients (n n¼28) 28) and patients who were diagnosed with deand patients who were diagnosed with depression after randomisation was closed pression after randomisation was closed ( (n n¼16), 331 patients were available for 16), 331 patients were available for randomisation. The intervention ( randomisation. The intervention (n n¼209) 209) and care as usual ( and care as usual (n n¼122) arms did not 122) arms did not differ with respect to demographics, depresdiffer with respect to demographics, depressive symptoms during hospitalisation (BDI sive symptoms during hospitalisation (BDI score), risk factors for coronary artery score), risk factors for coronary artery disease and important prognostic variables disease and important prognostic variables such as WMSI and comorbidity (Table 2) . such as WMSI and comorbidity (Table 2 ). In addition, there were no differences with In addition, there were no differences with respect to ICD-10 depression characterisrespect to ICD-10 depression characteristics (Table 3) . Seventeen patients (5%) were tics (Table 3) . Seventeen patients (5%) were lost to follow-up. lost to follow-up.
Antidepressant intervention Antidepressant intervention
Of the 196 patients assigned to the interOf the 196 patients assigned to the intervention and not lost to follow-up, 45 vention and not lost to follow-up, 45 (23%) did not receive antidepressant treat-(23%) did not receive antidepressant treatment, either because they refused to accept ment, either because they refused to accept the proposed therapy or because the psythe proposed therapy or because the psychiatrist did not confirm the diagnosis of chiatrist did not confirm the diagnosis of depression at the time of the visit. The depression at the time of the visit. The median length of time from the randomismedian length of time from the randomisation date to the first visit to the psyation date to the first visit to the psychiatrist was 13 days (interquartile range chiatrist was 13 days (interquartile range 7-21 days). The majority of patients in 7-21 days). The majority of patients in the intervention arm received clinical the intervention arm received clinical management of depression and 94 (45%) management of depression and 94 (45%) were enrolled in the double-blind placebowere enrolled in the double-blind placebocontrolled medication treatment sub-study. controlled medication treatment sub-study. Of these patients, 47 initially received Of these patients, 47 initially received mirtazapine and 44 initially received mirtazapine and 44 initially received placebo. Three patients received no treatplacebo. Three patients received no treatment because they failed to keep their ment because they failed to keep their appointment. Twenty patients originally appointment. (76) 159 (76) 90 (74) 90 (74) BMI BMI 5 525, 25, n n (%) (%) 129 (62) 129 (62) 75 (63) 75 (63) BDI score during hospitalisation mean: (s.d.) BDI score during hospitalisation mean: (s.d.) 11.9 (7.2) 11.9 (7.2) 11.7 (6.4) 11.7 (6.4) Diabetes mellitus, Diabetes mellitus, n n (%) (%) 30 (14) 30 (14) 15 (12) 15 (12) Hypertension, Hypertension, n n (%) (%) 73 (35) 73 (35) 43 (35) 43 (35) Dyslipidemia, Dyslipidemia, n n (%) (%) 174 (84) 174 (84) 103 (84) 103 (84) Family history of CAD, Family history of CAD, n n (%) (%) 104 (51) 104 (51) 62 (52) 62 (52) Smoking, Smoking, n n (%) (%) Resuscitation, Resuscitation, n n (%) (%) 18 (9) 18 (9) 17 (14) 17 (14) Thrombolysis, Thrombolysis, n n (%) (%) 72 (35) 72 (35) 55 (46) 55 (46) PTCA, PTCA, n n (%) (%) 96 (46) 96 (46) 60 (49) 60 (49) CABG, CABG, n n (%) (%) 10 (5) 10 (5) 5 (4) 5 (4) Medication at discharge, Medication at discharge, n n (%) (%) Acetylsalicylic acid Acetylsalicylic acid 172 (83) 172 (83) 109 (90) 109 (90) Acenocoumarol Acenocoumarol 28 (14) 28 (14) 14 (12) 14 (12) Nitrate Nitrate 74 (36) 74 (36) 48 (40) 48 (40) Beta-blocker Beta-blocker 178 (86) 178 (86) 102 (84) In contrast, only 8 patients (7%) in the In contrast, only 8 patients (7%) in the care as usual arm received antidepressant care as usual arm received antidepressant medication and 12 (10%) received nonmedication and 12 (10%) received nonpharmacological treatment for their pharmacological treatment for their depression (Fig. 1) . depression (Fig. 1) .
Effects on long-term depression Effects on long-term depression status status
Of the 307 patients who were alive at Of the 307 patients who were alive at 18 months and available for follow-up, 18 months and available for follow-up, depression assessments were obtained for depression assessments were obtained for 218 patients (71%), which was comparable 218 patients (71%), which was comparable for patients in the intervention (69%) and for patients in the intervention (69%) and care as usual arm (74%). The prevalence care as usual arm (74%). The prevalence of ICD-10 depression was 30.5% in the of ICD-10 depression was 30.5% in the patients assigned to the intervention and patients assigned to the intervention and 32.1% in the care as usual arm ( 32.1% in the care as usual arm (P P¼0.68; 0.68; Table 4 ). No significant differences were Table 4 ). No significant differences were observed between patients assigned to observed between patients assigned to intervention or care as usual with respect intervention or care as usual with respect to depressive symptoms, health complaints, to depressive symptoms, health complaints, disability and quality of life. disability and quality of life.
Treatment effect on cardiac Treatment effect on cardiac outcome outcome
The total event rate between randomisation The total event rate between randomisation and 18 months post-myocardial infarction and 18 months post-myocardial infarction was 42 out of 314 (13%, Table 5 ). The inwas 42 out of 314 (13%, Table 5 ). The incidence of events did not differ among the cidence of events did not differ among the two treatment strategies (13% in the care two treatment strategies (13% in the care as usual and 14% in the intervention arm, as usual and 14% in the intervention arm, log-rank test 0.09, log-rank test 0.09, P P¼0.76). Similarly, no 0.76). Similarly, no differences were observed in Kaplan-Meier differences were observed in Kaplan-Meier curves (Fig. 2) . The Cox regression analyses curves (Fig. 2) . The Cox regression analyses also revealed no differences between the also revealed no differences between the treatment arms (OR treatment arms (OR¼1.07, 95% CI 0.57-1.07, 95% CI 0.57-2.00). In addition, there were no differences 2.00). In addition, there were no differences in the incidence of cardiac events between in the incidence of cardiac events between patients in the intervention arm who patients in the intervention arm who received antidepressant medication (mirreceived antidepressant medication (mirtazapine tazapine n n¼47; open pharmacological 47; open pharmacological treatment treatment n n¼17) and non-responders to 17) and non-responders to placebo who received citalopram ( placebo who received citalopram (n n¼26) 26) (total (total n n¼90) compared with those patients 90) compared with those patients in the care as usual arm who received no in the care as usual arm who received no antidepressant treatment ( antidepressant treatment (n n¼98; OR 98; OR¼ 0.84, 95% CI 0.38-1.84; 14% 0.84, 95% CI 0.38-1.84; 14% v.
v. 12% 12% event rate). Within the intervention arm, event rate). Within the intervention arm, the event rate for patients receiving the event rate for patients receiving pharmacological treatment was 13%, pharmacological treatment was 13%, whereas this was 15% for patients who whereas this was 15% for patients who did not receive pharmacological treatment did not receive pharmacological treatment in the intervention arm (OR in the intervention arm (OR¼0.80, 95% 0.80, 95%
4 6 4 4 6 4 AUTHOR'S PROOF AUTHOR'S PROOF Table 3  Table 3 Characteristics of depression in the intervention and care as usual groups Characteristics of depression in the intervention and care as usual groups
Intervention group Intervention group ( (n n¼209) 209)
Care as usual group Care as usual group
Early-onset depression Early-onset depression 1 1
167 (80) 167 (80) 96 (80) 96 (80) Recurrent depression Recurrent depression 45 (22) 45 (22) 28 (23) (47) 98 (47) 58 (48) 58 (48) Severe Severe 46 (22) 46 (22) 28 (23) 28 (23) 1. Within 3 months of myocardial infarction. 1. Within 3 months of myocardial infarction. 
Cardiac death Cardiac death 1 (1) 1 (1) 3 (3) 3 (3)
Recurrent myocardial infarction Recurrent myocardial infarction 6 (3) 6 (3) 0 (0) 0 (0) Revascularisation (PTCA/CABG) Revascularisation (PTCA/CABG) 11 (6) 11 (6) 8 (7) 8 (7) Heart failure Heart failure 7 (4) 7 (4) 1 (1) 1 (1)
Ventricular arrhythmia Ventricular arrhythmia 1 (1) 1 (1) 1 (1) 1 (1) Total Total 27 (14) 27 (14) 15 (13) 15 (13) PTCA, percutaneous transluminal coronary angioplasty; CABG, coronary artery bypass grafting. PTCA, percutaneous transluminal coronary angioplasty; CABG, coronary artery bypass grafting. 1.75, 95% CI 0.46-6.59). The total rate for cardiac-related hospiThe total rate for cardiac-related hospitalisations between randomisation and 18 talisations between randomisation and 18 months post-myocardial infarction was months post-myocardial infarction was 127 out of 314 (40%). The incidences of 127 out of 314 (40%). The incidences of these secondary end-points were comparthese secondary end-points were comparable between patients allocated to intervenable between patients allocated to intervention and care as usual 77 of 196, 39% tion and care as usual 77 of 196, 39% v. v. 48 48 of 118, 41%, of 118, 41%, P P¼0.34). 0.34).
DISCUSSION DISCUSSION
We found that an active treatment strategy We found that an active treatment strategy for depression post-myocardial infarction for depression post-myocardial infarction did not improve the long-term depression did not improve the long-term depression status or cardiac prognosis compared with status or cardiac prognosis compared with usual care. At 18 months post-myocardial usual care. At 18 months post-myocardial infarction, about one-third of the interinfarction, about one-third of the intervention and control patients continued to vention and control patients continued to have ICD-10 depression. With respect to have ICD-10 depression. With respect to whether cardiac prognosis can be improved whether cardiac prognosis can be improved by treating depression effectively, the trial by treating depression effectively, the trial is inconclusive. Our findings are consistent is inconclusive. Our findings are consistent with the results of the ENRICHD study with the results of the ENRICHD study (Berkman (Berkman et al et al, 2003) that showed , 2003) that showed no overno overall effect of CBT on the risk of all-cause all effect of CBT on the risk of all-cause mortality and reinfarction in myocardial mortality and reinfarction in myocardial infarction patients with depression and/or infarction patients with depression and/or a low level of social support, and small a low level of social support, and small differences in depression between the differences in depression between the intervention and care as usual groups. intervention and care as usual groups.
Limitations Limitations
The lack of positive results in our trial The lack of positive results in our trial might be a result of either suboptimal antimight be a result of either suboptimal antidepressant treatment in the intervention depressant treatment in the intervention arm or better than expected treatment in arm or better than expected treatment in the care as usual arm. This possibility is the care as usual arm. This possibility is not supported by our secondary analyses not supported by our secondary analyses because comparing treated patients in the because comparing treated patients in the intervention arm with untreated patients intervention arm with untreated patients in the care as usual arm still yielded no in the care as usual arm still yielded no differences in the incidence of cardiac differences in the incidence of cardiac events. However, the data needed to deterevents. However, the data needed to determine whether optimal dosage and contimine whether optimal dosage and continuation of antidepressant treatment were nuation of antidepressant treatment were provided in the intervention arm were not provided in the intervention arm were not collected. collected.
It could also be argued that perhaps It could also be argued that perhaps these findings are the result of a large rate these findings are the result of a large rate of spontaneous recovery from depression of spontaneous recovery from depression which has been observed previously in both which has been observed previously in both ENRICHD and SADHART clinical trials. ENRICHD and SADHART clinical trials. Although this is plausible, our study was Although this is plausible, our study was not designed to evaluate this possibility in not designed to evaluate this possibility in detail since we used a Zelen design in which detail since we used a Zelen design in which the care as usual patients were not inthe care as usual patients were not informed about their depression and randomformed about their depression and randomisation status. The advantage of this design isation status. The advantage of this design is that usual care was truly representative is that usual care was truly representative but the disadvantage is that we cannot evalbut the disadvantage is that we cannot evaluate the (short-term) spontaneous recovery. uate the (short-term) spontaneous recovery. However, the fact that both arms were However, the fact that both arms were comparable in depression outcomes at 18 comparable in depression outcomes at 18 months does support this possibility. This months does support this possibility. This stresses the need to improve the identificastresses the need to improve the identification of patients with persistent depression tion of patients with persistent depression post-myocardial infarction in future clinical post-myocardial infarction in future clinical trials. trials.
An important limitation is the power of An important limitation is the power of the study. When the trial was initiated the the study. When the trial was initiated the results of the ENRICHD and SADHART results of the ENRICHD and SADHART trials had not been published and we had trials had not been published and we had to rely on data that in retrospect may have to rely on data that in retrospect may have been too optimistic (e.g. Frasure-Smith been too optimistic (e.g. Frasure-Smith et et al al, 1995) . First, the expected incidence of , 1995). First, the expected incidence of cardiac events was substantially higher than cardiac events was substantially higher than the observed incidence. Second, the associathe observed incidence. Second, the association between depression and cardiac outtion between depression and cardiac outcomes might have been overestimated and comes might have been overestimated and third, the anticipated effects of treatment third, the anticipated effects of treatment on depression were overly optimistic. As a on depression were overly optimistic. As a result, we believe that our study had suffiresult, we believe that our study had sufficient power to detect differences in longcient power to detect differences in longterm depression outcomes (standardised term depression outcomes (standardised effect size effect size 4 40.35) but was underpowered 0.35) but was underpowered to detect differences in cardiac outcomes. to detect differences in cardiac outcomes. However, the nearly identical long-term However, the nearly identical long-term depression status in the two arms and the depression status in the two arms and the similar rates of cardiac events offer little similar rates of cardiac events offer little evidence that a significant difference would evidence that a significant difference would have emerged if more patients had been have emerged if more patients had been included. Thus, although we believe that included. Thus, although we believe that our trial was underpowered, the obserour trial was underpowered, the observation that there were no consistent differvation that there were no consistent differences suggests that more study power ences suggests that more study power would very likely not have yielded different would very likely not have yielded different conclusions. conclusions.
Implications Implications
The MIND-IT produced null findings in The MIND-IT produced null findings in terms of long-term depression outcomes terms of long-term depression outcomes and was inconclusive about the effects of and was inconclusive about the effects of depression treatment on cardiac outcomes. depression treatment on cardiac outcomes. We were unable to substantially alter We were unable to substantially alter long-term depression status, and as a result long-term depression status, and as a result we still do not know whether effective we still do not know whether effective treatment of depression would result in a treatment of depression would result in a better cardiac prognosis. Future efforts better cardiac prognosis. Future efforts should focus on the identification and effecshould focus on the identification and effective treatment of patients with depression tive treatment of patients with depression post-myocardial infarction with different post-myocardial infarction with different antidepressant treatment modalities. In the antidepressant treatment modalities. In the absence of such knowledge, we did not absence of such knowledge, we did not choose one specific antidepressant therapy choose one specific antidepressant therapy but rather compared an active psychiatric but rather compared an active psychiatric intervention arm with care as usual. Unforintervention arm with care as usual. Unfortunately, this has resulted in a considerable tunately, this has resulted in a considerable proportion of patients that did not receive proportion of patients that did not receive antidepressant medication although being antidepressant medication although being in the intervention arm. When the efficacy in the intervention arm. When the efficacy of one antidepressant treatment has been of one antidepressant treatment has been proven, the next step should be to investiproven, the next step should be to investigate whether that treatment might improve gate whether that treatment might improve the impaired cardiac prognosis in this the impaired cardiac prognosis in this patient group. patient group.
Some recent findings suggest that Some recent findings suggest that particular subtypes of depression postparticular subtypes of depression postmyocardial infarction might be specifically myocardial infarction might be specifically related to impaired prognosis. We have related to impaired prognosis. We have found that only somatic/affective symptoms found that only somatic/affective symptoms are associated with a worsened cardiac are associated with a worsened cardiac prognosis ) is related to poor cardiac outcomes, and that even to poor cardiac outcomes, and that even minimal symptoms can have an effect (Bush minimal symptoms can have an effect (Bush et al et al, 2001) . We believe that the validity , 2001). We believe that the validity and homogeneity of the diagnosis and and homogeneity of the diagnosis and treatment of depression in acute coronary treatment of depression in acute coronary syndromes need to be reconsidered syndromes need to be reconsidered (Frasure-Smith & Lesperance, 2003) . This (Frasure-Smith & Lesperance, 2003) . This might lead to treatment strategies that might lead to treatment strategies that might be quite different from treatment might be quite different from treatment for depression in the general population for depression in the general population (American Psychiatric Association, 2000) (American Psychiatric Association, 2000) but be better adapted to cardiac care. but be better adapted to cardiac care.
